Enhanced dopamine release by nicotine in cigarette smokers

A double-blind, randomized, placebo-controlled pilot study

Hidehiko Takahashi, Yota Fujimura, Mika Hayashi, Harumasa Takano, Motoichiro Kato, Yoshiro Okubo, Iwao Kanno, Hiroshi Ito, Tetsuya Suhara

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Previous studies of smoking on dopamine release in humans were investigated only in smokers. Using nicotine gum, we examined the effect of nicotine on dopamine release in smokers and non-smokers and its relation to the degree of nicotine dependence. Smokers and non-smokers participated in a double-blind, randomized, placebo-controlled cross-over study. They participated in two PET measurements with [11C]raclopride, in which they received either nicotine or placebo. Changes in [11C]raclopride non-displaceable binding potential (BPND) following nicotine administration were quantified. Smokers showed significant decrease in BP in the striatum following nicotine administration, but non-smokers did not show such a decrease. The BPND difference between the two scanning sessions was correlated with the degree of nicotine dependence. The BPND difference might reflect enhanced dopamine release in smokers and the reinforced effect of nicotine. These data suggest the feasibility of our gum method as well as the importance of the degree of dependence in future studies of the nicotine effect on the dopamine system.

Original languageEnglish
Pages (from-to)413-417
Number of pages5
JournalInternational Journal of Neuropsychopharmacology
Volume11
Issue number3
DOIs
Publication statusPublished - 2008 May

Fingerprint

Nicotine
Tobacco Products
Dopamine
Placebos
Raclopride
Tobacco Use Disorder
Gingiva
Cross-Over Studies
Smoking

Keywords

  • Dependence
  • Dopamine
  • Nicotine
  • Positron emission tomography
  • Striatum

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Enhanced dopamine release by nicotine in cigarette smokers : A double-blind, randomized, placebo-controlled pilot study. / Takahashi, Hidehiko; Fujimura, Yota; Hayashi, Mika; Takano, Harumasa; Kato, Motoichiro; Okubo, Yoshiro; Kanno, Iwao; Ito, Hiroshi; Suhara, Tetsuya.

In: International Journal of Neuropsychopharmacology, Vol. 11, No. 3, 05.2008, p. 413-417.

Research output: Contribution to journalArticle

Takahashi, H, Fujimura, Y, Hayashi, M, Takano, H, Kato, M, Okubo, Y, Kanno, I, Ito, H & Suhara, T 2008, 'Enhanced dopamine release by nicotine in cigarette smokers: A double-blind, randomized, placebo-controlled pilot study', International Journal of Neuropsychopharmacology, vol. 11, no. 3, pp. 413-417. https://doi.org/10.1017/S1461145707008103
Takahashi, Hidehiko ; Fujimura, Yota ; Hayashi, Mika ; Takano, Harumasa ; Kato, Motoichiro ; Okubo, Yoshiro ; Kanno, Iwao ; Ito, Hiroshi ; Suhara, Tetsuya. / Enhanced dopamine release by nicotine in cigarette smokers : A double-blind, randomized, placebo-controlled pilot study. In: International Journal of Neuropsychopharmacology. 2008 ; Vol. 11, No. 3. pp. 413-417.
@article{68704e97d4c04a669e93d1c3e8b3cffa,
title = "Enhanced dopamine release by nicotine in cigarette smokers: A double-blind, randomized, placebo-controlled pilot study",
abstract = "Previous studies of smoking on dopamine release in humans were investigated only in smokers. Using nicotine gum, we examined the effect of nicotine on dopamine release in smokers and non-smokers and its relation to the degree of nicotine dependence. Smokers and non-smokers participated in a double-blind, randomized, placebo-controlled cross-over study. They participated in two PET measurements with [11C]raclopride, in which they received either nicotine or placebo. Changes in [11C]raclopride non-displaceable binding potential (BPND) following nicotine administration were quantified. Smokers showed significant decrease in BP in the striatum following nicotine administration, but non-smokers did not show such a decrease. The BPND difference between the two scanning sessions was correlated with the degree of nicotine dependence. The BPND difference might reflect enhanced dopamine release in smokers and the reinforced effect of nicotine. These data suggest the feasibility of our gum method as well as the importance of the degree of dependence in future studies of the nicotine effect on the dopamine system.",
keywords = "Dependence, Dopamine, Nicotine, Positron emission tomography, Striatum",
author = "Hidehiko Takahashi and Yota Fujimura and Mika Hayashi and Harumasa Takano and Motoichiro Kato and Yoshiro Okubo and Iwao Kanno and Hiroshi Ito and Tetsuya Suhara",
year = "2008",
month = "5",
doi = "10.1017/S1461145707008103",
language = "English",
volume = "11",
pages = "413--417",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Enhanced dopamine release by nicotine in cigarette smokers

T2 - A double-blind, randomized, placebo-controlled pilot study

AU - Takahashi, Hidehiko

AU - Fujimura, Yota

AU - Hayashi, Mika

AU - Takano, Harumasa

AU - Kato, Motoichiro

AU - Okubo, Yoshiro

AU - Kanno, Iwao

AU - Ito, Hiroshi

AU - Suhara, Tetsuya

PY - 2008/5

Y1 - 2008/5

N2 - Previous studies of smoking on dopamine release in humans were investigated only in smokers. Using nicotine gum, we examined the effect of nicotine on dopamine release in smokers and non-smokers and its relation to the degree of nicotine dependence. Smokers and non-smokers participated in a double-blind, randomized, placebo-controlled cross-over study. They participated in two PET measurements with [11C]raclopride, in which they received either nicotine or placebo. Changes in [11C]raclopride non-displaceable binding potential (BPND) following nicotine administration were quantified. Smokers showed significant decrease in BP in the striatum following nicotine administration, but non-smokers did not show such a decrease. The BPND difference between the two scanning sessions was correlated with the degree of nicotine dependence. The BPND difference might reflect enhanced dopamine release in smokers and the reinforced effect of nicotine. These data suggest the feasibility of our gum method as well as the importance of the degree of dependence in future studies of the nicotine effect on the dopamine system.

AB - Previous studies of smoking on dopamine release in humans were investigated only in smokers. Using nicotine gum, we examined the effect of nicotine on dopamine release in smokers and non-smokers and its relation to the degree of nicotine dependence. Smokers and non-smokers participated in a double-blind, randomized, placebo-controlled cross-over study. They participated in two PET measurements with [11C]raclopride, in which they received either nicotine or placebo. Changes in [11C]raclopride non-displaceable binding potential (BPND) following nicotine administration were quantified. Smokers showed significant decrease in BP in the striatum following nicotine administration, but non-smokers did not show such a decrease. The BPND difference between the two scanning sessions was correlated with the degree of nicotine dependence. The BPND difference might reflect enhanced dopamine release in smokers and the reinforced effect of nicotine. These data suggest the feasibility of our gum method as well as the importance of the degree of dependence in future studies of the nicotine effect on the dopamine system.

KW - Dependence

KW - Dopamine

KW - Nicotine

KW - Positron emission tomography

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=41649084731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649084731&partnerID=8YFLogxK

U2 - 10.1017/S1461145707008103

DO - 10.1017/S1461145707008103

M3 - Article

VL - 11

SP - 413

EP - 417

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 3

ER -